Self-Testing Market Size, Share, and Trends 2025 to 2034

Self-Testing Market Size and Growth 2025 to 2034

The global self-testing market size was valued at USD 11.45 billion in 2024 and is anticipated to reach around USD 22.41 billion by 2034, growing at a CAGR of 6.95% from 2025 to 2034. Benefits offered by self-testing include an easy and quick check for various illnesses and infections to help monitor and control health. This helps the growth of the market.

Self-Testing Market Key Takeaways

• North America dominated the market with the largest revenue share of 35% in 2024.
• Asia Pacific is estimated to host the fastest-growing market during the forecast period of 2025-2034.
• By product, the kits segment has held a major revenue share of 49% in 2024.
• By product type, the testing strips segment is expected to grow significantly in the market during the forecast period.
• By sample type, the blood sample segment has contributed more than 36% of revenue share in 2024.
• By sample type, the urine sample segment is expected to witness the fastest growth in the market during the forecast period.
• By application, the allergy test segment has recorded more than 19% of revenue share in 2024.
• By application, the cancer tests segment is expected to witness the fastest growth in the market during the forecast period. 
• By distribution channel, the offline segment has generated a major revenue share of 64%in 2024.
• By distribution channel, the online segment will expand rapidly during the forecast period.
• By usage, the disposable segment has captured the biggest revenue share of 83%  in 2024.
• By usage, the reusable segment will expand rapidly in the market during the forecast period.

Impact of AI on the Self-Testing Market

Artificial intelligence (AI) can be used to design and develop novel self-testing kits or equipment. It results in increased accuracy and precision, allowing physicians to make effective clinical decision-making. AI and machine learning (ML) algorithms can identify and quantify potential biomarkers involved in the disease. Disease testing software uses AI to enhance and streamline the testing process. AI and ML can also aid in determining the stage and severity of a disease. They can also predict the involvement of one chronic disorder with the other. AI and the Internet of Things (IoT) can enable the storing and sending of test data to patients and healthcare professionals. This allows patients and healthcare professionals to store vast amounts of data and access it at any time and from any place.

U.S. Self-Testing Market Size and Growth 2025 to 2034

The U.S. self-testing market size was estimated at USD 2.81 billion in 2024 and is predicted to be worth around USD 5.64 billion by 2034 with a CAGR of 7.22% from 2025 to 2034.

North America dominated the self-testing market in 2024. In North America, the increasing number of chronic conditions leads to the need for self-testing, which helps in a quick diagnosis of patients. In the United States, cancer is the leading cause of death, so there is a high demand for self-testing in this region. Favorable government support also contributes to the market. The U.S. government announced an investment of $600 million in 12 COVID home test manufacturers as cases and hospitalizations rise. In Canada, there is a high use of medical self-testing kits that may help to take an active role in improving and monitoring health. The Government of Canada also announced an investment of $17.9 million to increase access to HIV testing. These factors help the growth of the market in the North American region.

Asia Pacific is estimated to host the fastest-growing self-testing market during the forecast period of 2025-2034. Increased healthcare awareness and advanced technologies lead to the demand for home-based clinical laboratory equipment or self-testing equipment, which helps the growth of the market in the region. Rising government initiatives, improving healthcare sectors, and research and development of new therapies for infections factors help the growth of the market. In China, approximately 1.3 million people are estimated to be living with HIV by the end of 2023. In India, the HIV cases were found to be 2.5 million in 2023.

Market Overview

The self-testing market deals with manufacturers that are developing new kits for wellness and prevention strategies, ranging from chronic disorder management and acute infection diagnoses to detecting the potential risk of alignments. It is opening new ways to monitor, diagnose, and address patients and their treatment. The benefits of self-testing include monitoring and controlling your health.

Self-testing offers an effective and simple way to test for various illnesses and infections; it is easy to gain access to the tests that are needed. It also helps to monitor how your health changes over time. It helps to improve metacognitive skills, promotes anatomy, and helps to improve personal growth and mastery. These factors help to the growth of the market.

Self-Testing Market Growth Factors

• Rising Incidences of Chronic Disorders: The rising incidences of several disorders, such as infectious, inflammatory, and sexually transmitted diseases, require their early detection, promoting the development of self-testing kits.
• Favorable Government Policies: Several government organizations release guidelines and launch initiatives for screening and early detection of disease.
• Increasing Investments: Research institutions and pharmaceutical & biotechnology companies receive funding for developing novel and advanced research.
• Growing Research and Development: The growing research and development activities for developing self-testing kits and discovering biomarkers potentiate the market.
• Burgeoning Healthcare Sector: The burgeoning healthcare sector, due to increasing investments and favorable initiatives, promotes the market.
• Technological Advancements: Advanced technologies lead to innovative self-testing kits, resulting in more accurate diagnoses.
• Home Healthcare Services: The growing demand for home healthcare services due to the rising geriatric population propelling the market growth.
• Rising Disposable Income: The rising disposable income potentiates people to purchase self-testing kits for easy detection.

Self-Testing Market Scope

Market Dynamics

Driver

Favorable Government Support

The major growth factor of the self-testing market is favorable government support. Several government organizations and official agencies support the development of self-testing kits. These organizations encourage countries to initiate screening and early diagnosis of a disease, promoting the use of self-testing. The World Health Organization (WHO) launched the global health sector strategies (GHSSs) on HIV, viral hepatitis, and sexually transmitted diseases for 2022-2030 to end these diseases by 2030. The U.S. Food and Drug Administration also regulates self-testing kits developed for various diseases. These organizations also provide funding to accelerate the development process of self-testing kits. Additionally, increasing public-private partnerships helps the government achieve the desired goal of eliminating the disease.

Restraint

Diagnosis-related issues

Patients may misinterpret the test results, which may lead to trying the wrong therapies or medications or delay treatment or diagnosis. Some of the results of the tests may be tricky to interpret. Patients may improperly store the sample or mishandle the sample, which leads to inaccurate results. Patients may not choose the proper testing, which leads to anxiety and unnecessary spending. Disadvantages of self-testing include that without professional guidance, results may lead to unnecessary anxiety or false reassurance. These factors may restrict the growth of the self-testing market.

Opportunity

Research and development

In self-testing, the use of automation offers opportunities to improve tools and frameworks. Advanced technology use in self-testing helps to grow performance. This helps patients to make self-testing more user-friendly and accurate. Investment in the development of self-testing methods helps to the growth of the market. Autonomous testing is a growing technology that uses artificial intelligence (AI) or machine learning (ML) to create and drive software testing without human intervention. In self-testing, smart sensors can be used to perform self-diagnosis by internal signal monitoring for fault evidence. These factors help to the growth of the self-testing market.

Product Insights

The kits segment dominated the self-testing market in 2024. Self-testing kits are allowed for the individual to perform different disease tests in the comfort of their own homes. This is mainly helpful for those who have been in contact with an infected person and are experiencing symptoms. Self-testing kits have numerous benefits, including curating and rapid tests being performed in a short period of time. Self-testing kits cover the spectrum of health conditions ranging from preventive care to infectious diseases and some chronic diseases. These factors help to the growth of the kits product type segment and contribute to the growth of the market.

Type, the testing strips segment is expected to grow significantly in the self-testing market during the forecast period. For testing of urine and saliva, self-testing strips are used, like pH test strips. For blood glucose testing, blood testing strips are used. The benefits of self-testing strips include requiring a small amount of samples. Urine test strips may detect many urological, systematic, and metabolic conditions. These benefits help the growth of the testing strips product type segment and contribute to the growth of the market.

Sample Insights

The blood sample segment dominated the self-testing market in 2024. Self-testing of blood samples helps to avoid travel and the loss of time. Blood sample testing helps healthcare professionals or doctors identify many health conditions, including diabetes, cancer, HIV, organ failure, vitamin deficiencies, high cholesterol, anemia, infections, and others. Doctors or healthcare professionals use blood samples to analyze substance behaviors like chemicals, cells, or proteins in the blood. Testing of blood samples has the benefits of self-testing, which is much more accessible and convenient. These factors help to the growth of the blood sample type segment and contribute to the growth of the market.

The urine sample segment is expected to witness the fastest growth in the self-testing market during the forecast period. A urine sample test is used to detect and manage many disorders like diabetes, kidney diseases, liver diseases, urinary stones, and urinary tract infections. Urine sample testing involves checking the concentration, content, and appearance of urine. The urine sample test type is relatively less expensive. These factors help the growth of the urine sample type segment and contribute to the growth of the market.

Application Insights

The allergy test segment dominated the self-testing market in 2024. There are many benefits of allergy testing, including finding accurate treatment solutions, creating a manageable diet, making responsible choices, taking control of the environment, and preventing serious effects, which helps the growth of the segment. Allergy test information can help healthcare professionals develop allergy treatment plans, which include allergy treatment plans, medicines, or allergen avoidance. Allergy tests are highly used to help diagnose allergic conditions like hay fever, also known as allergic rhinitis. Blood samples can be used for the allergy test. Patch testing is commonly used to determine the cause of allergic skin inflammation. These factors help to the growth of the allergy application type segment and contribute to the growth of the market.

The cancer tests segment is expected to witness the fastest growth in the self-testing market during the forecast period. Self-testing cancer test kits help for the detection and screening of cancer in its early or more treatable stage or sometimes before an individual shows any symptoms. By finding changes in the body due to cancer can be prevented by cancer testing. These factors help the growth of the cancer tests application type segment and contribute to the growth of the market.

Distribution Channel Insights

The offline segment dominated the self-testing market in 2024. Offline distribution channels help to leverage retail partnerships, create memorable and engaging customer experiences, build loyalty and trust with customers, and maximize physical presence. For elderly persons, an offline distribution channel is a better option for those who are not active online. In offline distribution channels, customers can get their product home instantly by avoiding the wait for shipping. These factors help to the growth of the offline distribution channel type segment and contribute to the growth of the market.

The online segment will expand rapidly during the forecast period. The online distribution channel has an easier return and delivery system, easy inventory management, greater control, and more customers. It can help to set up the choice of payment modes and can offer many benefits to the buyers. It explores many varieties of products without leaving the comfort zone of their home. It also can compare prices effortlessly and quickly and sometimes may have access to better discounts and deals. These factors help the growth of the online distribution channel type segment and contribute to the growth of the market.

Usage Insights

The disposable segment dominated the self-testing market in 2024. Disposable usage type of self-testing has many advantages, including easy disposal, cost-effectiveness, increased convenience, decreased infection rates, and reduced risk of contamination. These factors help to the growth of the disposal usage type segment and contribute to the growth of the market.

The reusable segment will expand rapidly in the self-testing market during the forecast period. The reusable usage type self-testing has advantages, including saving money, helping for environmental sustainability for future generations, helping to reduce greenhouse gas emissions, saving energy, reducing the risk of injury to the staff, and preventing pollution caused by the necessity of new raw material harvesting. These factors help the growth of the reusable usage type segment and contribute to the growth of the market.

Self-Testing Market Companies

• ARKRAY Inc
• ACON Laboratories Inc
• Assure Tech (Hangzhou) Co. Ltd
• BD
• Bionime Corporation
• Becton, Dickinson & Company
• bioLytical Laboratories Inc
• B. Braun Holding GmbH
• Cardinal Health
• F. Hoffmann-La Roche Ltd
• Geratherm Medical AG
• Johnson & Johnson Services Inc
• OraSure Technologies, Inc
• Piramal Enterprises
• PRIMA Labs SA
• Quidel Corporation
• Roche Holding AG
• True Diagnostic Inc.

Latest Announcement by Industry Leaders

• Dr. Amardeep Singh Kohli, CEO of PSRI Hospital, New Delhi, anticipated the future of self-testing kits to expand into new therapeutic areas, driven by continuous advancements in diagnostic technologies. He added that the emerging areas include cardiovascular health, respiratory conditions, and infectious diseases.

Recent Developments

• In August 2023, in-home testing or self-testing for chronic kidney disease or diabetes was launched by Signify Health by expanding its services. The new screenings expanded on Signify Health’s services, providing home kidney health evaluations as part of an overall In-home Health Evaluation (IHE). 
• In September 2023, several self-diagnostic tests were launched by a new partnership between 2San and Phoenix Healthcare that helps to allow consumers to take care and control of their health and speed up diagnostics.
• In October 2023, clinical trial start-up Lindus Health and female-founded gynecological health start-up Daye launched their clinical trial for Diagnostic Tampon for at-home or self-testing STI and HPV testing.
• In November 2023, in Tesco, the first at-home testing or self-testing was launched for HIV. The test was designed to detect antibodies to HIV Virus Type 1 (HIV-1) and/or HIV Virus Type 2 (HIV-2) with more than 99% accuracy, all within 15 minutes. 
• In March 2024, the two boosts branded self-tests of vitamin-D and iron deficiency self-tests were launched by Abingdon Health. The company launched the two tests in Boots, the United Kingdom's leading health and beauty retailer, with the self-tests made available in their brick-and-mortar stores as well as online. 

Segments Covered in the Report

By Product

• Kits
• Devices
• Strips

By Sample

• Blood
• Urine
• Stool
• Others

By Application

• Blood Pressure Test
• Diabetes and Glucose Tests
• Cholesterol and Triglycerides Tests
• Pregnancy Test
• STD /STI Test
• Urinary Tract Infection Test
• Cancer Test
• Celiac Disease Test
• Thyroid Test
• Transaminase Test
• Anemia Test
• Allergy Test
• Others

By Distribution Channel

• Online
• Offline

By Usage

• Disposable
• Reusable

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa